Kaposi's Sarcoma of Tonsils

Abstract

Introduction: Kaposi's sarcoma is a common malignancy in HIV patients. The ENT manifestation of Kaposi's sarcoma is rare and constitutes a factor of poor prognosis. it is a mesenchymal proliferative process of cells of the blood and lymphatic systems, which is induced by viral growth factors, human herpes virus type 8 (HHV8). It is a common tumour in HIV immunocompromised patients. Case Presentation: Tonsil localization is rare, reporting to us the case of a patient for Behcet's disease undergoing immunosuppressive treatment presenting with a tonsillar manifestation of Kaposi's sarcoma unrelated to HIV immunosuppressive treatment is associated with an increased risk of Kaposi's sarcoma management of these tumours is difficult insofar as immunosuppression must be continued to prevent the occurrence of rejection. Clinical Discussion: The KS incidence in the general population is 1 case per 100,000 inhabitants Localization of Kaposi's sarcoma is rare in, Only 4 cases are reported in the literature. Treatment for Kaposi's sarcomas is based on radiotherapy, chemotherapy, surgery and interferons. Surgery is the reference treatment in the case of a small tumour, in a single location, within the same organ, without lymph node involvement. Conclusion: Isolated Kaposi's sarcoma of the tonsil is very rare and can simulate benign or malignant lesions, by data from the literature Symptoms vary according to the seat and volume of the lesion.